First licensed therapy for moderate-to-severe irritable bowel syndrome with constipation (IBS-C) included in NICE Guideline

Almirall welcomes the inclusion of Constella (linaclotide)1 within the irritable bowel syndrome (IBS) NICE Guideline CG61 (Update) for use in adult patients and recognises the...